Outcomes following RPE transplantation for AMD

Despite the great success of anti-VEGF therapy for wet AMD, there remains a need for alternative treatments for those patients that do not respond to anti-VEGF therapy, or have dry AMD. Surgical treatments, such as maculoplasty, are continuing to evolve. This study finds that maculoplasty is able to maintain the vision of most patients with...

Full Article

Benefits of the treat-and-extend approach for AMD therapy

The argument in favor of using Avastin over Lucentis is almost always economic. Because Avastin is much cheaper than Lucentis, patients and their insurance provider can save lots of money by using Avastin. However, the "treat and extend" dosing strategy reveals another potential benefit of Avastin - its longer half-life. There are several studies...

Full Article

Lucentis for wet AMD with very low vision

There is some controversy regarding the benefit of anti-VEGF therapy for patients with very poor vision and/or long-standing maculopathy. It is thought that many of these patients may have scarring of the macula that could prevent them from responding favorably to treatment. A few small studies have been performed on this patient population with...

Full Article

Pressure-lowering medication ineffective against IOP spikes after intravitreal injections

Very high IOP following intravitreal injection is a common and serious problem. Even transient pressure spikes can cause serious damage to the eye, and the risk is compounded by the necessity for repeated monthly injections. When a patient's IOP shoots up very high following an injection, fluid can be removed from the eye to rapidly return the...

Full Article